Inventor · disambiguated record
Cheng-Huei Hsiong
Also filed as: HSIONG CHENG-HUEI
9 granted patents·10 pending applications·49 citations·filing 2001–2024
85Inventor score
Top patents by PatentIndex Score
19 records- 0184US6703398B2Orally administered analgesic compositions containing nalbuphineHU OLIVER YOA-PU·Filed 2001·Granted Mar 9, 2004·17 cites·14 claims
- 0281US9415034B2Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)OLIVER YOA-PU HU·Filed 2008·Granted Aug 16, 2016·12 cites·2 claims
- 0381US2024335404A1Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseasesSINEW PHARMA INC·Filed 2024·Application pending·0 cites
- 0480US6544954B1Stable galactose injection solutionsHU OLIVER YOA-PU·Filed 2002·Granted Apr 8, 2003·12 cites·13 claims
- 0579US10456371B2Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseasesSINEW PHARMA INC·Filed 2016·Granted Oct 29, 2019·1 cites·34 claims
- 0675US6680067B2Controlled-release pharmaceutical preparation containing nalbuphine and a process for preparing the sameHU OLIVER YOA-PU·Filed 2001·Granted Jan 20, 2004·6 cites·19 claims
- 0774US12083088B2Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseasesSINEW PHARMA INC·Filed 2022·Granted Sep 10, 2024·0 cites·81 claims
- 0871US2013184227A1Cytochrome P450 2C9 InhibitorsHU OLIVER YOA-PU·Filed 2009·Application pending·0 cites
- 0968US11285123B2Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseasesSINEW PHARMA INC·Filed 2019·Granted Mar 29, 2022·0 cites·62 claims
- 1064US2014343116A1Cytochrome p450 2c9 inhibitorsNAT DEFENSE MEDICAL CT·Filed 2014·Application pending·0 cites
- 1161US7169763B2Cytochrome P450 3A inhibitors and enhancersHU OLIVER YOA-PU·Filed 2002·Granted Jan 30, 2007·1 cites·4 claims
- 1260US2006069042A1Cytochrome P450 2C9 inhibitorsHU OLIVER Y·Filed 2004·Application pending·0 cites
- 1359US2004171631A1Orally administered analgesic compositions containing nalbuphineFiled 2004·Application pending·0 cites
- 1455US10976322B2Galactose oral composition and use thereofAVALON HEPAPOC LTD·Filed 2018·Granted Apr 13, 2021·0 cites·15 claims
- 1546US2021008101A1Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap)SINEW PHARMA INC·Filed 2019·Application pending·0 cites
- 1645US2016184298A1Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2b (ugt2b)NAT DEFENSE MEDICAL CT·Filed 2016·Application pending·0 cites
- 1743US2017101678A1Method for screening risk of drug-induced toxicityRES CENTER FOR BIOTECHNOLOGY AND MEDICINE POLICY·Filed 2014·Application pending·0 cites
- 1841US2006040875A1Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)UNIV NAT DEFENSE·Filed 2005·Application pending·0 cites
- 1938US2003166583A1Dermal cytochrome P450 1A inhibitors and enhancersFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cheng-Huei Hsiong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →